Skip to main content

Takeda Pharmaceutical Company

Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Values in USD · ADR · Reports in JPY

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Current Price

$16.68

+0.60%

GoodMoat Value

$44.87

169.0% undervalued
Profile
Valuation (TTM)
Market Cap$52.11B
P/E73.27
EV
P/B1.12
Shares Out3.12B
P/Sales1.75
Revenue$29.80B
EV/EBITDA9.47

TAK (TAK) — Earnings Call Transcripts

No transcripts available yet

No earnings call transcripts are available for TAK yet. Check back after the next earnings report.

← Back to TAK overview